Community-acquired pneumonia (CAP) is one of the respiratory infectious diseases caused
by not only bacteria, but also viruses. Antibiotic agents are needed to treat only bacterial but …

Community-acquired pneumonia (CAP) is the leading cause of death from infectious
diseases worldwide, with an incidence of 0.3 to 0.5% in the adult population. A new …

Background Community-acquired pneumonia (CAP) is the most frequent infection-related
cause of death. The reference standard to diagnose CAP is a new infiltrate on chest …

Community-acquired pneumonia (CAP) exhibits mortality rates, between 20% and 50% in
severe cases. Biomarkers are useful tools for searching for antibiotic therapy modifications …

Background Community-acquired pneumonia (CAP) causes substantial morbidity and
mortality in adults worldwide. The etiology of CAP often remains uncertain, and therapy is …

During the past few years, biomarkers have emerged as an indispensible tool in the
diagnosis of pneumonia. To find an ideal diagnostic biomarker for pneumonia is not an easy …

Community-acquired pneumonia (CAP) is defined as an infection of the alveolar or gas-
exchanging portions of the lungs occurring outside the hospital, with clinical symptoms …

Serum markers should only be used as a complementary tool to support the current clinical
approach. Use of serum markers, in particular procalcitonin and C-reactive protein …

Community‐acquired pneumonia (CAP) is a dangerous disease caused by a spectrum of
bacterial and viral pathogens. The choice of specific therapy and the need for hospitalization …

Background: The added value of biomarkers, such as procalcitonin (PCT), C-reactive protein
(CRP), and white blood cells (WBC), as adjuncts to clinical risk scores for predicting the …